Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06859970 · ClinicalTrials.gov registry record · NA
An Early Feasibility Study Evaluation of an Implant Free Interatrial Shunt to Improve Heart Failure
A NA study of Heart Failure and Heart Failure With Reduced Ejection Fraction, sponsored by InterShunt Technologies.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 6
- Study locations
NCT06859970 is a NA study of Heart Failure and Heart Failure With Reduced Ejection Fraction that is actively recruiting participants, run by InterShunt Technologies. The registered enrollment target is 20 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (99% lower). The trial reports 6 study locations across 5 states.
The verdict
NCT06859970, a NA study of Heart Failure and Heart Failure With Reduced Ejection Fraction, is actively recruiting participants, sponsored by InterShunt Technologies.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of this early feasibility study is to evaluate the safety and feasibility of the device for percutaneous shunting of the interatrial septum and improvement of heart failure related symptoms. The primary goal is to determine if the device is safe to use. The findings from this study may be used to refine the intended patient population, the design of the device, or develop a subsequent randomized study.
Conditions Studied
Interventions
- DEVICE PAS-C System
Study Locations (6)
Ohio
- Christ Hospital - Cincinnati
- The Ohio State University - Columbus
Arkansas
- St. Bernard's Healthcare - Jonesboro
California
- Los Robles Health System - Thousand Oaks
Indiana
- Ascension St. Vincent Hospital - Indianapolis
Texas
- Methodist Healthcare - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-05-15 |
| Est. Completion | 2031-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06859970
The ClinicalTrials.gov registry entry for NCT06859970 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (99% lower). The listed sponsor is InterShunt Technologies, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which PAS-C System is the first listed.
NCT06859970 reports 6 study locations spanning 5 distinct geographic areas - top geographies include Ohio, Arkansas, California.
Frequently Asked Questions
What is clinical trial NCT06859970 about?
NCT06859970 is a clinical study titled "An Early Feasibility Study Evaluation of an Implant Free Interatrial Shunt to Improve Heart Failure". The purpose of this early feasibility study is to evaluate the safety and feasibility of the device for percutaneous shunting of the interatrial septum and improvement of heart failure related symptoms. The primary goal is to determine if the device is safe to use. The findings from this study may b...
What is the current status of trial NCT06859970?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-05-15. Estimated completion is 2031-09.
What conditions does trial NCT06859970 study?
This clinical trial studies the following conditions: Heart Failure, Heart Failure With Reduced Ejection Fraction, Heart Failure NYHA Class III, Ambulatory Heart Failure, NYHA Class IV.
What interventions are being tested in trial NCT06859970?
The interventions under investigation include: PAS-C System (DEVICE).
Who is sponsoring clinical trial NCT06859970?
This trial is sponsored by InterShunt Technologies, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06859970 being conducted?
This trial has 6 study locations across Arkansas, California, Indiana, Ohio, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.